The outcome of each approach based on a total of 72 cases.a
| Approach | Type of Tumor, N(%) | Compartment, Extra:Intra n = 28 | Total Blood Loss in mL | Total Operation Time in Minutes | SSI N/ Total N | Weakness N/ Total N | Any Form of Complication N/ Total N | Recurrence N/ Total N |
| Total, n = 72 | 19:9 | 2934 (150–19225) | 680 (245–1516) | 6/58 | 33/58 | 72/72 | 9/72 | |
|
Posterior
| Total, 35 (49%) | 14:9 | 2024 (150–5500) | 421 (245–675) | 0/21 | 9/21 | 35/35 | 3/25 |
| Primary malignant, 6 (17%) | 1:2 | 1462 (180–2688) | 476 (290–655) | 0/5 | 2/5 | 6/6 | 0/6 | |
| Primary benign (aggressive), 10 (29%) | 1:3 | 1702 (15–5500) | 449 (320–675) | 0/10 | 4/10 | 10/10 | 0/10 | |
| Metastasis, 19 (54%) | 11:4 | 2372 (1000–4000) | 388 (245–630) | 0/6 | 3/6 | 19/10 | 3/19 | |
|
Combined
| Total, 37 (51%) | 5:0 | 3794 (160–19225) | 926 (475–1516) | 6/37 | 24/37 | 37/37 | 4/37 |
| Primary malignant, 9 (24%) | 1:0 | 4273 (190–19225) | 856 (540–1325) | 3/9 | 8/9 | 9/9 | 3/9 | |
| Primary benign (aggressive), 18 (49%) | 1:0 | 3853 (160–12370) | 1083 (475–1516) | 3/18 | 12/18 | 18/18 | 1/18 | |
| Metastasis, 10 (27%) | 3:0 | 3257 (900–13460) | 704 (540–990) | 0/10 | 4/10 | 10/10 | 0/10 | |
aSSI and weakness data were available for only 58 cases. Extra:Intracompartment ratio data were available for only 28 cases
N, number of cases; SSI, surgical site infection.